FDA to Rebuild Clearance Processes for Medical Devices
At Market.us Scoop, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us Scoop. We appreciate your support and look forward to continuing to provide valuable insights for our audience.
It seems the Food and Drugs Administration of the United States wants control how companies bring brand-new technology to the world of medical devices. In a rather bold move, the agency has announced that it would be rebuilding some of the clearance processes for medical devices. It should be noted, however, that some of these said processes are more than 40 years old. According to the current scenario, newly-launched products are judged by comparing them with products that are decades old — a method that doesn’t sound scientific or practical. It’s all, however, going to change.
This decision was long overdue for an agency like FDA, which has been taking serious actions against existing options that may harm the end-user. Several reports and studies have made it clear in the past that the FDA methods used for certifying the medical devices are pretty outdated and that the process can put customers at risk. According to the official statement, the FDA Commissioner said that this revamping processes would make it easy for companies to bring new products. At least, the products would not have to be compared to decades-old counterparts from history, which is a great perk indeed.
“What we want to do is constantly push the market toward incorporating better technology and better capabilities by advancing the predicates and always looking forward so the … predicates the device companies are using as the basis of their approvals are constantly incorporating newer and better technology to make the devices better and safer,” the FDA commissioner was found saying in an interview to CNBC. It means that the FDA has two objectives with the rebuilding of 501(k) processes. First, it would be safer for the customers. Second, companies would be encouraged to rely on modern technologies without the concerns of user-safety.
With over four years of experience in the research industry, Kathleen is generally engrossed in market consulting projects, catering primarily to domains such as ICT, Health & Pharma, and packaging. She is highly proficient in managing both B2C and B2B projects, with an emphasis on consumer preference analysis, key executive interviews, etc. When Kathleen isn’t deconstructing market performance trajectories, she can be found hanging out with her pet cat ‘Sniffles’.
Latest from Author
- Backlog of Longest-Wait Patients Declined in England, NHS Says
- A Single Inoculation of Immune Proteins Can Protect Against Malaria For Months
- To fight melanoma, researchers develop a nanoparticle-vaccine combination
- Neuroimaging Shows That Social Isolation Changes the Brain Structure
- Americans with Boosters are More Likely to Get Covid-19 Infections